バイエル薬品株式会社に対し、副作用報告義務違反への改善指導を行いました｜厚生労働省
https://www.mhlw.go.jp/stf/houdou/0000179072.htmlバイエル薬品株式会社に対し、副作用報告義務違反への改善指導を行いました｜厚生労働省
Open the dedicated viewer to inspect the saved page with archive metadata pinned above it, similar to archive wrappers such as Web Gyotaku.
This is a self-contained HTML copy with CSS and images embedded, so it still renders even if the original page disappears.
The dedicated viewer keeps the original URL and saved timestamp visible while you review the archived HTML.
This page announces that Japan's Ministry of Health, Labour and Welfare issued improvement guidance to Bayer Yakuhin Ltd. for violations of adverse event reporting obligations. The company failed to report 86 cases of adverse effects from four drugs: Exarelto, Bayaspirin, Stivarga, and Nexavar, with delays up to approximately 4 years and 11 months. Violations resulted from insufficient employee awareness, redundant reporting confirmation issues, improper causality judgments, and inadequate self-inspection scope. No immediate safety measures were deemed necessary.
